{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:55Z","timestamp":1792785055316,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":93,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82172567"],"award-info":[{"award-number":["82172567"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Key Project of Science and Technology Innovation of Health Commission of Jiangxi Province","award":["2023ZD005 and 2024ZD008"],"award-info":[{"award-number":["2023ZD005 and 2024ZD008"]}],"id":[{"id":"https:\/\/ror.org\/03vc7fb96","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Key Project Jointly Constructed by the Ministry and the Province of Zhejiang Medical and Health Science and Technology","award":["WKJ-ZJ-260030"],"award-info":[{"award-number":["WKJ-ZJ-260030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61924-6","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:25:47Z","timestamp":1783751147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of CCL4-positive macrophages and their associated immune microenvironment in thymic epithelial tumors"],"prefix":"10.1038","volume":"16","author":[{"given":"Xuping","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"61924_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/his.15097","volume":"84","author":"J von der Th\u00fcsen","year":"2024","unstructured":"von der Th\u00fcsen, J. Thymic epithelial tumours: Histopathological classification and differential diagnosis. Histopathology 84, 196\u2013215 (2024).","journal-title":"Histopathology"},{"key":"61924_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jtho.2021.10.010","volume":"17","author":"A Marx","year":"2022","unstructured":"Marx, A. et al. The 2021 WHO classification of tumors of the thymus and mediastinum: What is new in thymic epithelial, germ cell, and mesenchymal tumors?. J. Thorac. Oncol. 17, 200\u2013213 (2022).","journal-title":"J. Thorac. Oncol."},{"key":"61924_CR3","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1007\/s11427-024-2839-4","volume":"68","author":"J Wang","year":"2025","unstructured":"Wang, J. et al. Insights into the characteristics of cancer incidence in China. Sci. China Life Sci. 68, 1512\u20131515 (2025).","journal-title":"Sci. China Life Sci."},{"key":"61924_CR4","doi-asserted-by":"publisher","first-page":"S1691","DOI":"10.1097\/JTO.0b013e3182254ac1","volume":"6","author":"J Huang","year":"2011","unstructured":"Huang, J. et al. Standard outcome measures for thymic malignancies. J. Thorac. Oncol. 6, S1691\u2013S1697 (2011).","journal-title":"J. Thorac. Oncol."},{"key":"61924_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14092060","volume":"14","author":"M Ballman","year":"2022","unstructured":"Ballman, M. et al. Immunotherapy for management of thymic epithelial tumors: A double-edged sword. Cancers 14, 2060 (2022).","journal-title":"Cancers"},{"key":"61924_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01772-4","volume":"22","author":"Y-Q Ao","year":"2023","unstructured":"Ao, Y.-Q. et al. Immunotherapy of thymic epithelial tumors: Molecular understandings and clinical perspectives. Mol. Cancer 22, 70 (2023).","journal-title":"Mol. Cancer"},{"key":"61924_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1442888","volume":"15","author":"C Biray Avci","year":"2024","unstructured":"Biray Avci, C. et al. Tumor microenvironment and cancer metastasis: Molecular mechanisms and therapeutic implications. Front. Pharmacol. 15, 1442888 (2024).","journal-title":"Front. Pharmacol."},{"key":"61924_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102491","volume":"91","author":"H Yang","year":"2024","unstructured":"Yang, H. et al. Metabolism and macrophages in the tumor microenvironment. Curr. Opin. Immunol. 91, 102491 (2024).","journal-title":"Curr. Opin. Immunol."},{"key":"61924_CR9","doi-asserted-by":"publisher","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","volume":"164","author":"CD Mills","year":"2000","unstructured":"Mills, C. D. et al. M-1\/M-2 macrophages and the Th1\/Th2 paradigm. J. Immunol. 164, 6166\u20136173 (2000).","journal-title":"J. Immunol."},{"key":"61924_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","volume":"79","author":"PJ Murray","year":"2017","unstructured":"Murray, P. J. Macrophage polarization. Annu. Rev. Physiol. 79, 541\u2013566 (2017).","journal-title":"Annu. Rev. Physiol."},{"key":"61924_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","volume":"41","author":"PJ Murray","year":"2014","unstructured":"Murray, P. J. et al. Macrophage activation and polarization: Nomenclature and experimental guidelines. Immunity 41, 14\u201320 (2014).","journal-title":"Immunity"},{"key":"61924_CR12","doi-asserted-by":"crossref","unstructured":"Shen, W. et al. Senescent macrophages in tumor: phenotypes, roles, and interventions. Cell Death & Disease 16(1), 677 (2025).","DOI":"10.1038\/s41419-025-08000-5"},{"key":"61924_CR13","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1158\/0008-5472.CAN-15-1330","volume":"75","author":"N G\u00fcl","year":"2015","unstructured":"G\u00fcl, N. & Van Egmond, M. Antibody-dependent phagocytosis of tumor cells by macrophages: A potent effector mechanism of monoclonal antibody therapy of cancer. Cancer Res. 75, 5008\u20135013 (2015).","journal-title":"Cancer Res."},{"key":"61924_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati, M. et al. Diversity, mechanisms, and significance of macrophage plasticity. Annu. Rev. Pathol. 15, 123\u2013147 (2020).","journal-title":"Annu. Rev. Pathol."},{"key":"61924_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A. et al. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"61924_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13046-025-03321-x","volume":"44","author":"S Dong","year":"2025","unstructured":"Dong, S. et al. MMP28 recruits M2-type tumor-associated macrophages through MAPK\/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pancreatic cancer. J. Exp. Clin. Cancer Res. 44, 60 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"61924_CR17","doi-asserted-by":"publisher","first-page":"6392","DOI":"10.7150\/thno.95766","volume":"14","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Hypoxia-driven M2-polarized macrophages facilitate the epithelial-mesenchymal transition of glioblastoma via extracellular vesicles. Theranostics 14, 6392 (2024).","journal-title":"Theranostics"},{"key":"61924_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003416","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. J. Immunother. Cancer 10, e003416 (2022).","journal-title":"J. Immunother. Cancer"},{"key":"61924_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1264774","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Novel tumor-associated macrophage populations and subpopulations by single cell RNA sequencing. Front. Immunol. 14, 1264774 (2023).","journal-title":"Front. Immunol."},{"key":"61924_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma, R. Y. et al. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 43, 546\u2013563 (2022).","journal-title":"Trends Immunol."},{"key":"61924_CR21","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti\u2010Tumor by Blocking Metabolic Interactions in Organoids. Adv. Sci. 11(42), 2406653 (2024).","DOI":"10.1002\/advs.202406653"},{"key":"61924_CR22","doi-asserted-by":"crossref","unstructured":"Xin, Z. et al. The immune landscape of human thymic epithelial tumors. Nat. Commun. 13, 5463 (2022).","DOI":"10.1038\/s41467-022-33170-7"},{"key":"61924_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A. et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"61924_CR24","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. DoubletFinder: Doublet detection in single-cell RNA sequencing data using artificial nearest neighbors. Cell Syst. 8, 329-337.e324 (2019).","journal-title":"Cell Syst."},{"key":"61924_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"61924_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"61924_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.687975","volume":"12","author":"D Zeng","year":"2021","unstructured":"Zeng, D. et al. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures. Front. Immunol. 12, 687975 (2021).","journal-title":"Front. Immunol."},{"key":"61924_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser, D. et al. OncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 22, bbab260 (2021).","journal-title":"Brief Bioinform."},{"key":"61924_CR29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi, E. et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell 174, 1293-1308.e1236 (2018).","journal-title":"Cell"},{"key":"61924_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189167","volume":"1879","author":"Q Huang","year":"2024","unstructured":"Huang, Q. et al. Thymic epithelial tumor medical treatment: A narrative review. Biochim. Biophys. Acta Rev. Cancer 1879, 189167 (2024).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"61924_CR31","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/S1470-2045(22)00558-7","volume":"23","author":"Y Shintani","year":"2022","unstructured":"Shintani, Y. & Funaki, S. New combination therapy for thymic epithelial tumours. Lancet Oncol. 23, 1237\u20131239 (2022).","journal-title":"Lancet Oncol."},{"key":"61924_CR32","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cncr.34678","volume":"129","author":"R Maniar","year":"2023","unstructured":"Maniar, R. & Loehrer, P. J. Sr. Understanding the landscape of immunotherapy in thymic epithelial tumors. Cancer 129, 1162\u20131172 (2023).","journal-title":"Cancer"},{"key":"61924_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/life13051170","volume":"13","author":"A Tartarone","year":"2023","unstructured":"Tartarone, A. et al. Current treatment approaches for thymic epithelial tumors. Life 13, 1170 (2023).","journal-title":"Life"},{"key":"61924_CR34","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jtho.2020.11.003","volume":"16","author":"G Giaccone","year":"2021","unstructured":"Giaccone, G. & Kim, C. Durable response in patients with thymic carcinoma treated with pembrolizumab after prolonged follow-up. J. Thorac. Oncol. 16, 483\u2013485 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"61924_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41698-025-01152-9","volume":"9","author":"Y Huang","year":"2025","unstructured":"Huang, Y. & Fang, W. TREM2-mediated regulation of myeloid cells in the tumor microenvironment: New insights and therapeutic prospects. NPJ Precis. Oncol. 9, 359 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"61924_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","volume":"12","author":"A Zlotnik","year":"2000","unstructured":"Zlotnik, A. & Yoshie, O. Chemokines: A new classification system and their role in immunity. Immunity 12, 121\u2013127 (2000).","journal-title":"Immunity"},{"key":"61924_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.147","volume":"3","author":"H Li","year":"2022","unstructured":"Li, H. et al. Role of chemokine systems in cancer and inflammatory diseases. MedComm 3, e147 (2022).","journal-title":"MedComm"},{"key":"61924_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","volume":"24","author":"TR Mempel","year":"2024","unstructured":"Mempel, T. R. et al. How chemokines organize the tumour microenvironment. Nat. Rev. Cancer 24, 28\u201350 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"61924_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22189804","volume":"22","author":"P Bule","year":"2021","unstructured":"Bule, P. et al. Chemokine-directed tumor microenvironment modulation in cancer immunotherapy. Int. J. Mol. Sci. 22, 9804 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"61924_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49495-4","volume":"15","author":"Z-X Yan","year":"2024","unstructured":"Yan, Z.-X. et al. Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nat. Commun. 15, 5183 (2024).","journal-title":"Nat. Commun."},{"key":"61924_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1072","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients. Clin. Transl. Med. 12, e1072 (2022).","journal-title":"Clin. Transl. Med."},{"key":"61924_CR42","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1158\/1535-7163.MCT-16-0866","volume":"16","author":"J-Y Ao","year":"2017","unstructured":"Ao, J.-Y. et al. Colony-stimulating factor 1 receptor blockade inhibits tumor growth by altering the polarization of tumor-associated macrophages in hepatocellular carcinoma. Mol. Cancer Ther. 16, 1544\u20131554 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"61924_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2022.02.019","volume":"77","author":"C-Y Wei","year":"2022","unstructured":"Wei, C.-Y. et al. PKC\u03b1\/ZFP64\/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma. J. Hepatol. 77, 163\u2013176 (2022).","journal-title":"J. Hepatol."},{"key":"61924_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","volume":"31","author":"KA Reiss","year":"2025","unstructured":"Reiss, K. A. et al. CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: A phase 1 trial. Nat. Med. 31, 1171\u20131182 (2025).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61924-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61924-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:02:44Z","timestamp":1791810164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61924-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61924"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61924-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"31833"}}